These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1597134)

  • 1. The effect of 22-oxacalcitriol on serum calcitriol.
    Dusso AS; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
    Endocrinology; 1992 Jun; 130(6):3129-34. PubMed ID: 1597134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
    J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
    Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
    Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.
    Slatopolsky E; Cozzolino M; Finch JL
    Kidney Int; 2002 Oct; 62(4):1277-84. PubMed ID: 12234297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
    Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.
    Rodriguez M; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
    J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ; Ritter CR; Finch JL; Morrissey J; Martin KJ; Murayama E; Nishii Y; Slatopolsky E
    J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
    Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H
    Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
    Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
    Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
    Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
    J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
    Fan SL; Schroeder NJ; Calverley MJ; Burrin JM; Makin HL; Cunningham J
    Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3.
    Rader JI; Baylink DJ; Hughes MR; Safilian EF; Haussler MR
    Am J Physiol; 1979 Feb; 236(2):E118-22. PubMed ID: 420284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
    Jung S; Querfeld U; Müller D; Rudolph B; Peters H; Krämer S
    J Hypertens; 2012 Nov; 30(11):2182-91. PubMed ID: 22902873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.